DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man, Didier Meulendijks, Geert W.J. Frederix, Emma Kienhuis, Geert Jan Creemers, Arnold Baars, Vincent O. Dezentjé, Alexander L.T. Imholz, Frank J.F. Jeurissen, Johanna E.A. Portielje, Rob L.H. Jansen, Paul Hamberg, Albert J. ten Tije, Helga J. Droogendijk, Miriam Koopman, Peter Nieboer, Marlène H.W. van de Poel, Caroline M.P.W. MandigersHilde Rosing, Jos H. Beijnen, Erik van Werkhoven, André B.P. van Kuilenburg, Ron H.N. van Schaik, Ron H.J. Mathijssen, Jesse J. Swen, Hans Gelderblom, Annemieke Cats, Henk Jan Guchelaar, Jan H.M. Schellens*

*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

278 Citations (Scopus)

Fingerprint

Dive into the research topics of 'DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology